Trial Profile
Clinical Trials Insight: 700009573
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 01 Dec 2005
Price :
$35
*
At a glance
- Drugs Tacrolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Sponsors Sorin Group
- 01 Dec 2005 New trial record.